Company: THC
Filing Date: 2025-04-11
Form Type: DEF 14A
Source: 0001193125-25-079143
Chunk: 86

Company: TENET HEALTHCARE CORP
Filing Date: 2025-04-11
Form: DEF 14A
Chunk 86
---
-crisis/ 3 https://www.cms.gov/newsroom/press-releases/cms-announces-new-policies-reduce-maternal-mortality-increase-access-
care-and-advance-health-equity 4https://www.cms.gov/medicare/health-safety-standards/conditions-coverage-participation

| 84 |

Proposal 4 - Shareholder Proposal to Report on Strategies and Programs for Improving Maternal Health Outcomes The Board’s Statement in Opposition The proposal’s request that the Company “issue a public report detailing strategies and programs for improving maternal health outcomes” is unnecessary because the Company already devotes significant resources towards fulfilling the proposal’s central objective—which is improving maternal health outcomes, including by reducing the incidence of maternal mortality and severe maternal morbidities. Regarding the proposal’s additional request that the Company “publicly disclose to shareholders” certain “data collected from patients at [Company] facilities” and “the programs and services deployed,” the Company firmly believes that such public disclosure would not be in the best interest of our patients or our shareholders. The Company is committed to delivering comprehensive, best-in-classhealthcare to all patients across our entire network of facilities, which includes ensuring the health and safety of our pregnant, birthing and postpartum patients. We operate a confidential internal reporting system through which we require our healthcare providers to report all adverse events on a real-time basis. Reports are reviewed to identify controllable factors that may contribute to these events and assure prompt and sustainable remediation. Though the Company sees patient, provider and facility-specific data as a powerful tool for monitoring and improving our delivery of healthcare services, we do not believe that the public disclosures requested by the report would be in the best interest of our patients or our shareholders and would potentially create exposure for the Company in patient litigation. We have legal and ethical obligations to protect our patients’ privacy, and we are skeptical of the proposal’s underlying premise that shareholders have the necessary medical expertise required to evaluate our healthcare professionals’ “strategies and programs for improving maternal health outcomes.” As a prime example of why we believe the requested report is unnecessary, we note the supporting statement’s specific reference to certain obstetric care-related Conditions of Participation (the “CoPs”) announced in 2024 by the Centers for Medicare & Medicaid Services (“CMS”). The supporting statement implies that the report requested by the proposal would help investors to determine whether the Company’s facilities are compliant with the newly announced CoPs or whether they may otherwise “represent a risk” to the Company. The Company